Increased survival of free fat grafts and vascularization in rats with local delivery of fragmin/protamine microparticles containing FGF-2 (F/P MP-F)

J Biomed Mater Res B Appl Biomater. 2011 Feb;96(2):234-41. doi: 10.1002/jbm.b.31757. Epub 2010 Nov 22.

Abstract

We evaluated the effects of fragmin/protamine micro-particles (F/P MPs) containing FGF-2 (F/P MP-F) as carriers for the controlled release of FGF-2 for adipocyte-survival and capillary formation in inbred rats with subdivided free fat grafts. F/P MPs could immobilize FGF-2, thereafter gradually releasing the bound FGF-2. Inbred Fisher 344 rats weighing around 150 g were anesthetized and implanted with paste comprising harvested fat combined with F/P MP-F. The effect of F/P MP-F on the survival, granulation, and capillary formation in fat grafts was histologically compared with control grafts containing either FGF-2, F/P MPs or PBS. The control fat grafts became attached to tissues adjacent to the implantation site and were significantly resorbed after 30 days. In contrast, pink, soft, supple grafts were compressible and were little resorbed in the group given F/P FP MP-F at 30-120 days. Normal adipocytes were obviously decreased in the control groups with increased granulation tissues, whereas normal adipocytes with capillary formations were maintained in the F/P MP-F group. Thus, adding F/P MP-F to subdivided fat grafts helps to improve graft volume retention and survival in soft-tissue reconstruction through accelerating adipocyte-survival rates and angiogenesis.

MeSH terms

  • Adipocytes / cytology*
  • Adipocytes / transplantation
  • Adipose Tissue / transplantation*
  • Animals
  • Anticoagulants
  • Cell Survival
  • Dalteparin / therapeutic use
  • Drug Carriers / chemistry*
  • Fibroblast Growth Factor 2 / administration & dosage*
  • Fibroblast Growth Factor 2 / pharmacology
  • Graft Survival / drug effects*
  • Heparin Antagonists
  • Neovascularization, Physiologic / drug effects*
  • Protamines / therapeutic use
  • Rats
  • Rats, Inbred F344

Substances

  • Anticoagulants
  • Drug Carriers
  • Heparin Antagonists
  • Protamines
  • Fibroblast Growth Factor 2
  • Dalteparin